- Poster presentation
- Open Access
Influence of peri-infarct dysglycaemia on myocardial infarct size and its effect on cardiovascular outcome as determined by cardiovascular magnetic resonance imaging
© Mather et al; licensee BioMed Central Ltd. 2010
Published: 21 January 2010
Improved outcomes for normoglycaemic patients suffering acute myocardial infarction (AMI) over the last decade have not been matched by similar improvements in mortality for diabetic patients despite similar levels of baseline risk and appropriate medical therapy. The reasons for this disparity in outcome are not completely understood.
The purpose of this study was to determine if peri-infarct glycaemic control has an impact on myocardial infarct size, left ventricular ejection fraction (LVEF) and prognosis.
Ninety-three patients with first acute myocardial infarction (AMI) were studied. 22 patients had diabetes mellitus (DM) based on prior history or admission blood glucose ≥ 11.1 mmol/l. 13 patients had dysglycaemia (admission blood glucose ≥ 7.8 mmol/l but <11.1 mmol/l) and 58 patients had normoglycaemia (admission blood glucose <7.8 mmol/l). Patients underwent CMR imaging at index presentation and at median follow-up of 11 months. The CMR protocol was identical for all patients and included cine imaging and late gadolinium enhancement.
This study highlights the prognostic significance of peri-infarct glycaemic control in patients with AMI. Patients with dysglycaemia or DM appear to have larger infarct sizes and lower LVEF as determined by CMR, than normoglycaemic patients. This may, in part, account for their adverse prognosis.
This article is published under license to BioMed Central Ltd.